Aspirin and Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: Weighing the Evidence

  1. Mary B. Barton, MD, MPP; and
  2. Marion M. Torchia
  1. From the Agency for Healthcare Research and Quality, Rockville, MD 20850.

    IN RESPONSE:

    We want to respond to Dr. Stürmer and colleagues, regarding the systematic review posting on the Agency for Healthcare Research and Quality Web site The appendices were inadvertently omitted from the Web posting. The mistake has been corrected, and the full systematic review is now available on the Web site at http://www.ahrq.gov/clinic/uspstf07/aspcolo/aspcoloes.pdf(1). We regret the frustration this error has caused.

     
    Next Section

    Mary B. Barton, MD, MPP

    Marion M. Torchia

    Agency for Healthcare Research and Quality

    Rockville, MD 20850

    Previous SectionNext Section

    Article and Author Information

    • Potential Financial Conflicts of Interest: None disclosed.

    Previous Section
     

    Reference

    1. 1.↵
      Rostom A, Dubé C, Lewin G, Tsertsvadze A, Barrowman N, Code C, et al. Use of aspirin and NSAIDs to prevent colorectal cancer. Evidence Synthesis no. 45 (Prepared by the University of Ottawa Evidence-based Practice Center at The University of Ottawa under contract no. 290-02-0021). Bethesda, MD: Agency for Healthcare Research and Quality; March 2007. AHRQ publication no. 07-0596-EF-1. Accessed at http://www.ahrq.gov/clinic/uspstf07/aspcolo/aspcoloes.pdf on 28 August 2007.
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med November 6, 2007 vol. 147 no. 9 674-675
    1. ExcerptFREE
    2. » Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Navigate This Article

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues